Anne Bernhardt

Dr. Anne Bernhardt

Centre for Translational Bone, Joint and Soft Tissue Research, Medical Faculty and University Hospital “Carl Gustav Carus”, 01307 Dresden, Germany
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Anne BernhardtAnne Bernhardt
Anne Bernhardt
MWMarkus Wehrl
Markus Wehrl
BPBirgit Paul
Birgit Paul
THThomas Hochmuth
Thomas Hochmuth
MSMatthias Schumacher
Matthias Schumacher
Michael GelinskyMichael Gelinsky
Michael Gelinsky
The development of bio-resorbable implant materials is rapidly going on. Sterilization of those materials is inevitable to assure the hygienic requirements for critical medical devices according to the medical device directive (MDD, 93/42/EG). Biopolymer-containing biomaterials are often highly sensitive towards classical sterilization procedures like steam, ethylene oxide treatment or gamma irradiation. Supercritical CO2 (scCO2) treatment is a promising strategy for the terminal sterilization of sensitive biomaterials at low temperature. In combination with low amounts of additives scCO2 treatment effectively inactivates microorganisms including bacterial spores. We established a scCO2 sterilization procedure under addition of 0.25% water, 0.15% hydrogen peroxide and 0.5% acetic anhydride. The procedure was successfully tested for the inactivation of a wide panel of microorganisms including endospores of different bacterial species, vegetative cells of gram positive and negative bacteria including mycobacteria, fungi including yeast, and bacteriophages. For robust testing of the sterilization effect with regard to later application of implant materials sterilization all microorganisms were embedded in alginate/agarose cylinders that were used as Process Challenge Devices (PCD). These PCD served as surrogate models for bioresorbable 3D scaffolds. Furthermore, the impact of scCO2 sterilization on mechanical properties of polysaccharide-based hydrogels and collagen-based scaffolds was analyzed. The procedure was shown to be less compromising on mechanical and rheological properties compared to established low-temperature sterilization methods like gamma irradiation and ethylene oxide exposure as well as conventional steam sterilization. Cytocompatibility of alginate gels and scaffolds from mineralized collagen was compared after sterilization with ethylene oxide, gamma irradiation, steam sterilization and scCO2 treatment. Human mesenchymal stem cell viability and proliferation were not compromised by scCO2 treatment of these materials and scaffolds. We conclude that scCO2 sterilization under addition of water, hydrogen peroxide and acetic anhydride is a very effective, gentle, non-cytotoxic and thus a promising alternative sterilization method especially for biomaterials.

1 June 2016 in Acta Biomaterialia
Verified
Journal Article
Closed access
MSMatthias Schumacher
Matthias Schumacher
AWA.S. Wagner
A.S. Wagner
JKJ. Kokesch-Himmelreich
J. Kokesch-Himmelreich
Anne BernhardtAnne Bernhardt
Anne Bernhardt
MRM. Rohnke
M. Rohnke
Michael GelinskyMichael Gelinsky
Michael Gelinsky

1 July 2016 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
WPW. Pustlauk
W. Pustlauk
BPB. Paul
B. Paul
Michael GelinskyMichael Gelinsky
Michael Gelinsky
Anne BernhardtAnne Bernhardt
Anne Bernhardt

1 February 2021 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Anne BernhardtAnne Bernhardt
Anne Bernhardt
JSJakob Schneider
Jakob Schneider
ASAndreas Schroeder
Andreas Schroeder
KPKiriaki Papadopoulous
Kiriaki Papadopoulous
ELElena Lopez
Elena Lopez
UBUte Botzenhart
Ute Botzenhart

Verified
Journal Article
Open access
PDF file
JSJasmin Skottke
Jasmin Skottke
Michael GelinskyMichael Gelinsky
Michael Gelinsky
Anne BernhardtAnne Bernhardt
Anne Bernhardt
Background: Osteocytes are the key regulator cells in bone tissue, affecting activity of both osteoblasts and osteoclasts. Current in vitro studies on osteocyte-osteoblast interaction are invariably performed with rodent cells, mostly murine cell lines, which diminishes the clinical relevance of the data. Objective: The objective of the present study was to establish an in vitro co-culture system of osteoblasts and osteocytes, which is based solely on human primary cells. Methods: Three different approaches for the generation of human primary osteocytes were compared: direct isolation of osteocytes from bone tissue by multistep digestion, long-time differentiation of human pre-osteoblasts embedded in collagen gels, and short time differentiation of mature human osteoblasts in collagen gels. Co-cultivation of mature osteoblasts with osteocytes, derived from the three different approaches was performed in a transwell system, with osteocytes, embedded in collagen gels at the apical side and osteoblasts on the basal side of a porous membrane, which allowed the separate gene expression analysis for osteocytes and osteoblasts. Fluorescence microscopic imaging and gene expression analysis were performed separately for osteocytes and osteoblasts. Results: All examined approaches provided cells with typical osteocytic morphology, which expressed osteocyte markers E11, osteocalcin, phosphate regulating endopeptidase homolog, X-linked (PHEX), matrix extracellular phosphoglycoprotein (MEPE), sclerostin, and receptor activator of NF-κB Ligand (RANKL). Expression of osteocyte markers was not significantly changed in the presence of osteoblasts. In contrast, osteocalcin gene expression of osteoblasts was significantly upregulated in all examined co-cultures with differentiated osteocytes. Alkaline phosphatase (ALPL), bone sialoprotein II (BSPII), and RANKL expression of osteoblasts was not significantly changed in the co-culture. Conclusion: Interaction of osteoblasts and osteocytes can be monitored in an in vitro model, comprising solely primary human cells.

13 March 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Anne BernhardtAnne Bernhardt
Anne Bernhardt
BPBirgit Paul
Birgit Paul
Michael GelinskyMichael Gelinsky
Michael Gelinsky
Background: Collagens of marine origin are applied increasingly as alternatives to mammalian collagens in tissue engineering. The aim of the present study was to develop a biphasic scaffold from exclusively marine collagens supporting both osteogenic and chondrogenic differentiation and to find a suitable setup for in vitro chondrogenic and osteogenic differentiation of human mesenchymal stroma cells (hMSC). Methods: Biphasic scaffolds from biomimetically mineralized salmon collagen and fibrillized jellyfish collagen were fabricated by joint freeze-drying and crosslinking. Different experiments were performed to analyze the influence of cell density and TGF-β on osteogenic differentiation of the cells in the scaffolds. Gene expression analysis and analysis of cartilage extracellular matrix components were performed and activity of alkaline phosphatase was determined. Furthermore, histological sections of differentiated cells in the biphasic scaffolds were analyzed. Results: Stable biphasic scaffolds from two different marine collagens were prepared. An in vitro setup for osteochondral differentiation was developed involving (1) different seeding densities in the phases; (2) additional application of alginate hydrogel in the chondral part; (3) pre-differentiation and sequential seeding of the scaffolds and (4) osteochondral medium. Spatially separated osteogenic and chondrogenic differentiation of hMSC was achieved in this setup, while osteochondral medium in combination with the biphasic scaffolds alone was not sufficient to reach this ambition. Conclusions: Biphasic, but monolithic scaffolds from exclusively marine collagens are suitable for the development of osteochondral constructs.